| Authors: |
Lecocq Q; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Awad RM; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., De Vlaeminck Y; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., de Mey W; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Ertveldt T; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Goyvaerts C; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Raes G; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Thielemans K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Keyaerts M; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium; and.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium., Devoogdt N; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium; and nick.devoogdt@vub.be karine.breckpot@vub.be., Breckpot K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium. |